Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719990 | SCV000515046 | likely benign | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000458625 | SCV000556479 | benign | Tuberous sclerosis 2 | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022413 | SCV001184145 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000458625 | SCV002039460 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001022413 | SCV002533534 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-10 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002502485 | SCV002809607 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-03-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995995 | SCV004824779 | likely benign | Tuberous sclerosis syndrome | 2024-09-26 | criteria provided, single submitter | clinical testing |